Biotech Brittany Trang STAT Plus: ‘Are we better off with the information?’: Experts spar over the benefits of liquid biopsy to catch cancer
Biotech Matthew Herper STAT Plus: A new list ranks large pharmaceutical companies by research and development
Biotech Jason Mast STAT Plus: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way
Biotech Angus Chen STAT Plus: CAR-T research is flourishing but is hampered by outdated precautions, experts say
Biotech Damian Garde STAT Plus: For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest
Biotech Jason Mast STAT Plus: Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity
Biotech Matthew Herper and Adam Feuerstein STAT Plus: Eli Lilly’s Alzheimer’s therapy slowed patients’ rate of cognitive decline, data show
Biotech Adam Feuerstein and Damian Garde STAT Plus: What to know about the upcoming readout of Eli Lilly’s experimental Alzheimer’s therapy
Biotech Jonathan Wosen STAT Plus: Travere Therapeutics drug, approved for one rare and deadly kidney disease, fails in study of another
Biotech Jason Mast STAT Plus: Astellas acquires Iveric Bio for $5.9B, entering competition to treat common cause of vision loss
Biotech Damian Garde STAT Plus: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’
Pharmalot Andrew Joseph STAT Plus: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability
Biotech Matthew Herper STAT Plus: FDA warns of security vulnerability in Illumina’s DNA sequencing machines
Pharmalot Andrew Joseph STAT Plus: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent
Biotech Matthew Herper STAT Plus: Eli Lilly’s Mounjaro succeeds in second weight loss study, paving way for FDA review
Biotech Allison DeAngelis STAT Plus: Six months after launch, Bert Vogelstein’s latest blood testing startup gets acquired for $450 million
Politics Rachel Cohrs and Sarah Owermohle STAT Plus: Pharma executives shower Bill Cassidy with campaign cash
Exclusive Jason Mast STAT Plus: Early findings in gene therapy death suggest CRISPR was not the cause
Pharmalot Damian Garde STAT Plus: Pharmalittle: EU unveils sweeping pharma reforms; new eye drug helps Roche beat the street
Politics John Wilkerson STAT Plus: Medicare official insists drug price negotiation will consider value of drugs
Politics Rachel Cohrs STAT Plus: Sens. Bernie Sanders, Bill Cassidy reach deal on PBM, generic reform
Pharmalot Damian Garde STAT Plus: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline